You have 9 free searches left this month | for more free features.

Disease Free Survival

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prognostic Factors Affecting Recurrence and Disease-Free

Recruiting
  • Rectal Cancer
  • curative surgery for cancer rectum
  • Qinā, Egypt
    Qena Faculty of Medicine, South Valley University Hospitals
Oct 21, 2023

Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Neoadjuvant
  • Axitinib plus Toripalimab
  • radical nephrectomy
  • (no location specified)
Feb 12, 2023

Disease-free Survival of High-risk Head-neck Cutaneous Squamous

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +5 more
  • Treatment
  • Maastricht, Netherlands
  • +1 more
Apr 26, 2023

Textbook Outcome in Colon Carcinoma

Completed
  • Outcome Assessment
  • Cancer of Colon
  • Colon oncological resection
  • Alicante, Spain
    Hospital General Universitario Dr. Balmis
Jan 5, 2023

Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

Recruiting
  • Prostate Cancer
  • +2 more
  • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
  • +7 more
  • Quebec, Canada
    CHUdeQuebec
Apr 7, 2023

Metastatic Cancer Trial in Besançon, Montbéliard (Additional biological samples)

Recruiting
  • Metastatic Cancer
  • Additional biological samples
  • Besançon, France
  • +1 more
May 10, 2022

to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

Recruiting
  • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
  • Capecitabine 500Mg Oral Tablet
  • Shanghai, China
    Eye & ENT Hospital, Fudan University
Jul 2, 2023

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Surgical Complications and DFS in Obese Rectal Cancer Patients

Recruiting
  • Obesity, Morbid
  • +2 more
  • BIB positioning
  • Naples, Italy
    Nunzio Velotti
Sep 27, 2023

Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

Recruiting
  • Disease Free Survival
  • +2 more
  • use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
  • Milan, Italy
    IRCCS San Raffaele
Mar 7, 2022

Contrast-enhanced CT-based Deep Learning Model for Preoperative

Recruiting
  • Predictive Ability of Contrast-enhanced CT-based Deep Learning Model in Patients With Localised ccRCC
  • +2 more
    • Chongqing, Chongqing, China
      Yingjie Xv
    Oct 12, 2023

    dataBase for Analysis of Rectal Cancer Oncological Results

    Recruiting
    • Rectal Cancer
    • +4 more
    • Krakow, Malopolska, Poland
      1st Department of General Surgery
    Jul 3, 2022

    Disease-free Survival Trial in Shanghai (MBF-RIC)

    Recruiting
    • Disease-free Survival
    • Shanghai, Shanghai, China
    • +1 more
    Jun 28, 2022

    Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

    Completed
    • The Primary Study Metric is Progression-free Survival (PFS)
      • (no location specified)
      Jun 28, 2023

      Sarcoma Trial in Baltimore, Minneapolis (biological, drug, procedure, radiation)

      Active, not recruiting
      • Sarcoma
      • pegfilgrastim
      • +5 more
      • Baltimore, Maryland
      • +1 more
      Mar 25, 2022

      Breast Tumors Trial in Benxi, Shengyang, Shenyang (Expanded Mckissock surgery, Modified radical mastectomy)

      Recruiting
      • Breast Neoplasms
      • Expanded Mckissock surgery
      • Modified radical mastectomy
      • Benxi, Liaoning, China
      • +2 more
      Feb 6, 2022

      Rectal Cancer Trial in United States (drug, radiation, behavioral, procedure)

      Active, not recruiting
      • Rectal Cancer
      • Oxaliplatin (OXAL)
      • +6 more
      • Irvine, California
      • +25 more
      Jan 12, 2023

      Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

      Completed
      • Acute Lymphoblastic Leukemia
        • Brno, Czechia
        • +9 more
        Sep 12, 2022

        Progression Free Survival(PFS) Trial (Toposide capsules combined with anrotinib and Emvolizumab group)

        Not yet recruiting
        • Progression Free Survival(PFS)
        • Toposide capsules combined with anrotinib and Emvolizumab group
        • (no location specified)
        Jan 13, 2023

        Head and Neck Mucosal Melanomas Trial in Villejuif (drug, procedure, radiation)

        Recruiting
        • Head and Neck Mucosal Melanomas
        • Villejuif, Val De Marne, France
          Gustave Roussy
        Jul 21, 2021

        Waldenstrom's Disease, Prognostic Index Trial in France

        Not yet recruiting
        • Waldenstrom's Disease
        • Prognostic Index
          • Amiens, France
          • +14 more
          Jun 12, 2023

          Stage III Gastric Cancer Trial in Nanjing (ONS)

          Not yet recruiting
          • Stage III Gastric Cancer
          • ONS
          • Nanjing, Jiangsu, China
            Jinling Hospital, China
          Jul 25, 2022

          Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

          Recruiting
          • Prostate Cancer
          • +6 more
          • Radiotherapy (SBRT) and/or surgery (metastasectomy)
          • +2 more
          • Leuven, Belgium
            University Hospitals Leuven
          Jun 7, 2022

          Circumferential Resection Margin, Intraoperative Perforation of Rectum, Local Recurrence of Malignant Tumor of Rectum Trial in

          Recruiting
          • Circumferential Resection Margin
          • +4 more
          • neoadjuvant chemoradiotherapy
          • Beijing, Beijing, China
            Beijing Chaoyang Hospital
          Feb 4, 2021

          Multiple Myeloma Trial in Creteil (Whole Body Dynamic Contrast Enhanced MRI (WB-DCE-MRI))

          Completed
          • Multiple Myeloma
          • Whole Body Dynamic Contrast Enhanced MRI (WB-DCE-MRI)
          • Creteil, France
            Henri Mondor Hospital
          Nov 19, 2020